A rare disease refers to a condition, disorder, or illness that impacts fewer than 200,000 people in the United States. As reported by the National Organization for Rare Disorders, there are more than 10,000 such rare diseases, collectively affecting over 30 million Americans. Over 80% of the rare diseases are said to be genetic in origin.
The stock we are bringing to your attention today is that of Sarepta Therapeutics Inc. (SRPT), which is developing treatments for some of the world's most debilitating, prevalent, and complex rare genetic diseases like Duchenne muscular dystrophy, limb-girdle muscular dystrophies, and Charcot-Marie-Tooth disease.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.